Printer-friendly version
3C Patch® is made from the patient's own blood with no additional reagents or additives. The three layer patch includes fibrin for moisture retention and strength, platelets for growth factor release and leukocytes from the patient's blood.
• Effective
• Clinically proven in a large RCT (Lancet 2018)
• Fully autologous
• Automated system
• Easy to use
• Cost effective
The 3C Patch® System is intended to be used at point-of-care for the safe and rapid preparation of platelet-rich plasma (PRP) gel from a small sample of a patient's own peripheral blood. Under the supervision of a health care professional, the PRP gel produced by the 3C Patch® System is topically applied for the management of exuding cutaneous wounds, such as leg ulcers, pressure ulcers and diabetic ulcers and mechanically or surgically debrided wounds.
Contraindicated for use on actively infected wounds, patients with malignant wounds, patients with sepsis or bacteraemia, patients with large wounds, active systemic disorders and abnormal laboratory tests. See instruction for use for further details.
Federal Law (U.S.A.) restricts this device to sale by or on the order of a physician. Throughout the processing and application of 3C Patch®, use universal precautions as defined by the facility policy and procedure manual.
Store at ambient temperature.
| Contact manufacturer for details | |
| FDA cleared/approved for bone/tendon | ● |
| FDA cleared/approved for burns | ● |
| Kit components included | ● |
| No centrifuge required | |
| Portable preparation device | ● |
| Same day procurement application | ● |
| Educational Material Available | ● |
| Free Samples/Trials Available | ● |
| Published Clinical Article Available | ● |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Granulating/Epithelializing Wounds
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Pressure Ulcers
Sloughy Wounds
Superficial Wounds
Surgical Wounds
Venous Ulcers
The 3CP™ Centrifuge and the 3CP® Device work together as a system. The sterile 3C Patch® Device is a precision engineered mini cell processor working together with the specially designed centrifuge that drives the patented 3CP® System to form the autologous leukocyte and platelet rich fibrin patch (The 3C Patch®) from an 18ml blood sample. The 3C Patch® is applied directly to the wound surface and covered with the supplied non-adherent dressing.
3C Patch® is applied weekly.
Reapplix, the developer of 3C Patch®, is an emerging force in regenerative medicine fully committed to improving the lives of patients.